Mdr1a Publications

Mdr1a Model Page

Filter publications by application: All
Filter publications by model type: All

Author(s)

(Date)

Paper Title

Citation

Model Type

Applications

Full Text

Schinkel AH, et al.
Mouse over for full list
Schinkel AH, Smit JJ, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CA, van der Valk MA, Robanus-Maandag EC, te Riele HP
(1994) Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77(4):491-502
Zhou S, et al.
Mouse over for full list
Zhou S, Morris JJ, Barnes Y, Lan L, Schuetz JD, Sorrentino BP
(2002) Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo. Proc. Natl. Acad. Sci. U.S.A. 99(19):12339-44
Schinkel AH, et al.
Mouse over for full list
Schinkel AH, Schuetz EG, Relling MV, Schuetz JD
(1996) P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans Proc Natl Acad Sci USA. 93:4001-5
Schinkel AH, et al.
Mouse over for full list
Schinkel AH, Wagenaar E, Mol C A, van Deemter L
(1996) P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest. 97(11): 2517-2524
Sparreboom A, et al.
Mouse over for full list
Sparreboom A, van Asperen J, Mayer U, Schinkel AH, Smit JW, Meijer DK, Borst P, Nooijen WJ, Beijnen JH, van Tellingen O
(1997) Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc. Natl. Acad. Sci. U.S.A. 94(5):2031-5
Neudeck BL, et al.
Mouse over for full list
Neudeck BL, Loeb JM, Faith NG, Czuprynski CJ
(2004) Intestinal P Glycoprotein Acts as a Natural Defense Mechanism against Listeria monocytogenes Infect Immun. 72(7):3849-3854
Maggio-Price L, et al.
Mouse over for full list
Maggio-Price L, Bielefeldt-Ohmann H, Treuting P, Iritani BM, Zeng W, Nicks A, Tsang M, Shows D, Morrissey P, Viney JL
(2005) Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a-/- mice results in colitis that progresses to dysplasia. Am. J. Pathol. 166(6):1793-806
Maggio-Price L, et al.
Mouse over for full list
Maggio-Price L, Shows D, Waggie K, Burich A, Zeng W, Escobar S, Morrissey P, Viney JL
(2002) Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice. Am. J. Pathol. 160(2):739-51
Cirrito JR, et al.
Mouse over for full list
Cirrito JR, Deane R, Fagan AM, Spinner ML, Parsadanian M, Finn MB, Jiang H, Prior JL, Sagare A, Bales KR, Paul SM, Zlokovic BV, Piwnica-Worms D, Holtzman DM
(2005) P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. J. Clin. Invest. 115(11):3285-90
Miyama T, et al.
Mouse over for full list
Miyama T, Takanaga H, Matsuo H, Yamano K, Yamamoto K, Iga T, Naito M, Tsuruo T, Ishizuka H, Kawahara Y, Sawada Y
(1998) P-glycoprotein-mediated transport of itraconazole across the blood-brain barrier. Antimicrob. Agents Chemother. 42(7):1738-44